GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Advance Bio-Pharmaceutical Inc (ROCO:4186) » Definitions » Total Debt per Share

Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Total Debt per Share : NT$3.28 (As of Jun. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Taiwan Advance Bio-Pharmaceutical Total Debt per Share?

NT$3.28 (As of Jun. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Taiwan Advance Bio-Pharmaceutical's Total Debt Per Share for the quarter that ended in Jun. 2024 was NT$3.28.

Taiwan Advance Bio-Pharmaceutical Total Debt per Share Historical Data

The historical data trend for Taiwan Advance Bio-Pharmaceutical's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Advance Bio-Pharmaceutical Total Debt per Share Chart

Taiwan Advance Bio-Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.35 3.05 2.85 3.23 3.56

Taiwan Advance Bio-Pharmaceutical Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.85 3.23 3.71 3.56 3.28

Taiwan Advance Bio-Pharmaceutical Total Debt per Share Calculation

Taiwan Advance Bio-Pharmaceutical's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(86.9+233.2)/90.0
=3.56

Taiwan Advance Bio-Pharmaceutical's Total Debt Per Share for the quarter that ended in Jun. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(70.5+224.9)/90.0
=3.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiwan Advance Bio-Pharmaceutical Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Taiwan Advance Bio-Pharmaceutical's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiwan Advance Bio-Pharmaceutical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Advance Bio-Pharmaceutical Inc (ROCO:4186) » Definitions » Total Debt per Share
Comparable Companies
ROCO:4195 ROCO:3205 ROCO:6827 ROCO:6709 ROCO:6850 ROCO:6872 ROCO:6810 ROCO:6610 ROCO:4171 ROCO:4192 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
12F., No.25, Ln. 169, Kangning Street, Xizhi Dist, New Taipei City, TWN, 22180
Website
http://www.abc-residue.com
Taiwan Advance Bio-Pharmaceutical Inc operates in the food safety industry. The company's product includes Food safety test kit, Animal test kit, Pesticide test kit, Mycotoxin test kit, Nuleic acid extraction kit.

Taiwan Advance Bio-Pharmaceutical Headlines

No Headlines